Replies to post #179568 on Biotech Values

[pollyvonwog]

I think would be disappointed (but not devastated of course :)) with anything below $1.5b. Considering what MRK paid for IDIX's nukes as well as what seems like a real interest by NVS in advancing ENTAs compound, I would like to think $1.5b would be the minimum someone would have to pay.